PET Imaging for Breast Cancer
- PMID: 34392915
- DOI: 10.1016/j.rcl.2021.05.004
PET Imaging for Breast Cancer
Abstract
Imaging plays an integral role in the clinical care of patients with breast cancer. This review article focuses on the use of PET imaging for breast cancer, highlighting the clinical indications and limitations of 2-deoxy-2-[18F]fluoro-d-glucose (FDG) PET/CT, the potential use of PET/MRI, and 16α-[18F]fluoroestradiol (FES), a newly approved radiopharmaceutical for estrogen receptor imaging.
Keywords: (18)F-FDG; (18)F-FES; Breast cancer; Computed tomography; Magnetic resonance imaging; Positron emission tomography.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The University of Wisconsin School of Medicine and Public Health Department of Radiology receives research support from GE Healthcare.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
